Rating History for Apellis Pharmaceuticals (APLS) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for APLS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/21/2026 Tazeen Ahmad Upgrade Buy
(Neutral)		 28.00
(N/A)		 20.47
(20.07)		 -1.95% Details